Cargando…
Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine
ABSTRACT: Cytochrome P450 (CYP) 2S1 is “orphan” CYP that is overexpressed in several epithelial tissues and many human tumors. The pure enzyme is required for better understanding of its biological functions. Therefore, human CYP2S1 was considered to be prepared by the gene manipulations and heterol...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828499/ https://www.ncbi.nlm.nih.gov/pubmed/27110039 http://dx.doi.org/10.1007/s00706-016-1738-2 |
_version_ | 1782426589905027072 |
---|---|
author | Mrízová, Iveta Moserová, Michaela Milichovský, Jan Šulc, Miroslav Kizek, René Kubáčková, Kateřina Arlt, Volker M. Stiborová, Marie |
author_facet | Mrízová, Iveta Moserová, Michaela Milichovský, Jan Šulc, Miroslav Kizek, René Kubáčková, Kateřina Arlt, Volker M. Stiborová, Marie |
author_sort | Mrízová, Iveta |
collection | PubMed |
description | ABSTRACT: Cytochrome P450 (CYP) 2S1 is “orphan” CYP that is overexpressed in several epithelial tissues and many human tumors. The pure enzyme is required for better understanding of its biological functions. Therefore, human CYP2S1 was considered to be prepared by the gene manipulations and heterologous expression in Escherichia coli. Here, the conditions suitable for efficient expression of human CYP2S1 protein from plasmid pCW containing the human CYP2S1 gene were optimized and the enzyme purified to homogeneity. The identity of CYP2S1 as the product of heterologous expression was confirmed by dodecyl sulfate–polyacrylamide gel electrophoresis, Western blotting, and mass spectrometry. To confirm the presence of the enzymatically active CYP2S1, the CO spectrum of purified CYP2S1 was recorded. Since CYP2S1 was shown to catalyze oxidation of compounds having polycyclic aromatic structures, the prepared enzyme has been tested to metabolize the compounds having this structural character; namely, the human carcinogen benzo[a]pyrene (BaP), its 7,8-dihydrodiol derivative, and an anticancer drug ellipticine. Reaction mixtures contained besides the test compounds the CYP2S1 enzyme reconstituted with NADPH:CYP reductase (POR) in liposomes, and/or this CYP in the presence of cumene hydroperoxide or hydrogen peroxide. High performance liquid chromatography was employed for separation of BaP, BaP-7,8-dihydrodiol, and ellipticine metabolites. The results found in this study demonstrate that CYP2S1 in the presence of cumene hydroperoxide or hydrogen peroxide catalyzes oxidation of two of the test xenobiotics, a metabolite of BaP, BaP-7,8-dihydrodiol, and ellipticine. Whereas BaP-7,8,9,10-tetrahydrotetrol was formed as a product of BaP-7,8-dihydrodiol oxidation, ellipticine was oxidized to 12-hydroxyellipticine, 13-hydroxyellipticine, and the ellipticine N(2)-oxide. GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00706-016-1738-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4828499 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-48284992016-04-21 Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine Mrízová, Iveta Moserová, Michaela Milichovský, Jan Šulc, Miroslav Kizek, René Kubáčková, Kateřina Arlt, Volker M. Stiborová, Marie Monatsh Chem Original Paper ABSTRACT: Cytochrome P450 (CYP) 2S1 is “orphan” CYP that is overexpressed in several epithelial tissues and many human tumors. The pure enzyme is required for better understanding of its biological functions. Therefore, human CYP2S1 was considered to be prepared by the gene manipulations and heterologous expression in Escherichia coli. Here, the conditions suitable for efficient expression of human CYP2S1 protein from plasmid pCW containing the human CYP2S1 gene were optimized and the enzyme purified to homogeneity. The identity of CYP2S1 as the product of heterologous expression was confirmed by dodecyl sulfate–polyacrylamide gel electrophoresis, Western blotting, and mass spectrometry. To confirm the presence of the enzymatically active CYP2S1, the CO spectrum of purified CYP2S1 was recorded. Since CYP2S1 was shown to catalyze oxidation of compounds having polycyclic aromatic structures, the prepared enzyme has been tested to metabolize the compounds having this structural character; namely, the human carcinogen benzo[a]pyrene (BaP), its 7,8-dihydrodiol derivative, and an anticancer drug ellipticine. Reaction mixtures contained besides the test compounds the CYP2S1 enzyme reconstituted with NADPH:CYP reductase (POR) in liposomes, and/or this CYP in the presence of cumene hydroperoxide or hydrogen peroxide. High performance liquid chromatography was employed for separation of BaP, BaP-7,8-dihydrodiol, and ellipticine metabolites. The results found in this study demonstrate that CYP2S1 in the presence of cumene hydroperoxide or hydrogen peroxide catalyzes oxidation of two of the test xenobiotics, a metabolite of BaP, BaP-7,8-dihydrodiol, and ellipticine. Whereas BaP-7,8,9,10-tetrahydrotetrol was formed as a product of BaP-7,8-dihydrodiol oxidation, ellipticine was oxidized to 12-hydroxyellipticine, 13-hydroxyellipticine, and the ellipticine N(2)-oxide. GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00706-016-1738-2) contains supplementary material, which is available to authorized users. Springer Vienna 2016-03-30 2016 /pmc/articles/PMC4828499/ /pubmed/27110039 http://dx.doi.org/10.1007/s00706-016-1738-2 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Paper Mrízová, Iveta Moserová, Michaela Milichovský, Jan Šulc, Miroslav Kizek, René Kubáčková, Kateřina Arlt, Volker M. Stiborová, Marie Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine |
title | Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine |
title_full | Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine |
title_fullStr | Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine |
title_full_unstemmed | Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine |
title_short | Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine |
title_sort | heterologous expression of human cytochrome p450 2s1 in escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828499/ https://www.ncbi.nlm.nih.gov/pubmed/27110039 http://dx.doi.org/10.1007/s00706-016-1738-2 |
work_keys_str_mv | AT mrizovaiveta heterologousexpressionofhumancytochromep4502s1inescherichiacoliandinvestigationofitsroleinmetabolismofbenzoapyreneandellipticine AT moserovamichaela heterologousexpressionofhumancytochromep4502s1inescherichiacoliandinvestigationofitsroleinmetabolismofbenzoapyreneandellipticine AT milichovskyjan heterologousexpressionofhumancytochromep4502s1inescherichiacoliandinvestigationofitsroleinmetabolismofbenzoapyreneandellipticine AT sulcmiroslav heterologousexpressionofhumancytochromep4502s1inescherichiacoliandinvestigationofitsroleinmetabolismofbenzoapyreneandellipticine AT kizekrene heterologousexpressionofhumancytochromep4502s1inescherichiacoliandinvestigationofitsroleinmetabolismofbenzoapyreneandellipticine AT kubackovakaterina heterologousexpressionofhumancytochromep4502s1inescherichiacoliandinvestigationofitsroleinmetabolismofbenzoapyreneandellipticine AT arltvolkerm heterologousexpressionofhumancytochromep4502s1inescherichiacoliandinvestigationofitsroleinmetabolismofbenzoapyreneandellipticine AT stiborovamarie heterologousexpressionofhumancytochromep4502s1inescherichiacoliandinvestigationofitsroleinmetabolismofbenzoapyreneandellipticine |